Prevention of diabetes in NOD mice by a mutated I-Ab transgene

Diabetes

Volumn 47, Issue 10, 1998, Pages 1570-1577

  Singer, Steven M ^a   Tisch, Roland ^a   Yang, Xiao Dong ^a   Sytwu, Huey Kang ^a   Liblau, Roland ^a   McDevitt, Hugh O ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PANCREAS ISLET CELL ANTIBODY;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE PREDISPOSITION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; MUTAGENESIS, SITE-DIRECTED; T-LYMPHOCYTES;

EID: 0031690196     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.10.1570     Document Type: Article

References (59)

1. Todd JA: Genetic control of autoimmunity in type I diabetes. Immunol Today 11:122-129, 1990
2. Makino S, Kimimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y: Breeding of a non-obese, diabetic strain of mice. Exp Anim 29:1-13, 1980
3. Leiter E, Serreze DV: Antigen presenting cells and the immunogenetics of autoimmune diabetes in NOD mice. Reg Immunol 4:263-273, 1992
4. Palmer JP, Asplin CM, Clemons P, Lyen K, Tapati O, Raghu P, Paquette TL: Insulin autoantibodies in insulin dependent diabetes before insulin treatment. Science 222:1337-1339, 1984
5. Baekkeskov S, Aanstoot H, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizmg enzyme glutamic acid dercarboxylase. Nature 347:151-156, 1990
6. Roep BO, Arden SD, de Vries RRP, Hutton JC: T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345:632-634, 1990
7. Elias D, Markovits D, Reshef T, van der Zee R, Cohen IR: Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci U S A 87:1576-1580, 1990
8. Castano L, Russo E, Zhou L, Lipes MA, Eisenbarth GS: Identification and cloning of a granule autoantigen (carboxypeptidase H) associated with type I diabetes. J Clin Endocrinol Metab 73:1197-1201, 1991
9. Boitard C, Villa MC, Becourt C, Gia HP, Sempe P, Portier MM, Bach JF: Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. Proc Natl Acad Sci U S A 89:172-176, 1992
10. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature 366:72-75, 1993
11. Kaufman DL, Clare-Salzer M, Tian J, Forsthuber T, Ting GSP, Robertson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993
12. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo YLS, Martin S, Martin A, Powers AC, Prochaxka M, Naggert J, Leiter EH, Eisenbarth GS: Islet cell antigen 69-kD (ICA-69): molecular cloning and characterization of a novel diabetes- associated autoantigen. J Clin Invest 92:359-371, 1993
13. + subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140:52-58, 1988
14. Shizuru J, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG: Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T helper lymphocytes. Science 240:659-662, 1988
15. Bendelac A, Boitard C, Bedoosa P, Bazin H, Bach J-F, Carnaud C: Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol 141:2625-2628, 1988
16. Hayward A, Schreiber M: Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes. J Immunol 143:1555-1559, 1989
17. Charlton B, Bacelj A, Mandel TE: Administration of silica particles or anti-Lyt-2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 37:930-935, 1988
18. Hutchings P, Rosen H, O'Reffly L, Simpson E, Gordon S, Cooke A: Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348:639-642, 1990
19. a donors. Diabetes 42:44-55, 1993
20. Bedossa P, Bendelac A, Bach JF, Carnaud C: Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction. Eur J Immunol 19:1947-1951, 1989
21. Nagata M, Yokono K, Hayakawa M, Kawase Y, Hatamori N, Ogawa W, Yonezawa K, Shii K, Baba S: Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice. J Immunol 143:1155-1162, 1989
22. Rabinovitch A: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 43:61:3-621, 1994
23. Coffman RL, Seymour BWP, Lebman DA, Hiraki DD, Christiansen JA, Shrader B, Cherwinski HM, Savelkoul HFJ, Finkelman FD, Bond MW, Mosmann TR: The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 102:5-28, 1988
24. Liblau RS, Singer SM, McDevitt HO: Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38, 1995
25. Tisch R, McDevitt HO: Insulin-dependent diabetes mellitus. Cell 85:291-297, 1996
26. Scott B, Liblau R, Degermann S, Marconi LA, Ogata L, Caton AJ, McDevitt HO, Lo D: A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73-83, 1994
27. Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H, Strauss WM, Seidman JG, Eisenbarth GS: The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231:733-735, 1986
28. Prochazka M, Leiter E, Serreze D, Coleman D: Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice. Science 237:286-289, 1987
29. Wicker L, Miller BJ, Coker LZ, McNally SE, Scott S, Mullen Y, Appel MC: Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 166:1639-1654, 1987
30. β chain is unique. Proc Natl Acad Sci U S A 84:2435-2439, 1987
31. Nishimoto H, Kikutani H, Yamamura K, Kishimoto T: Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328:432-434, 1987
32. k transgenic mice. Intl Immunol 1:209-213, 1989
33. k transgpnic mice. Nature 345:724-726, 1990
34. Lund T, O'Reilly L, Hutchings P, Kanagawa O, Simpson E, Gravely R, Chandler P, Dyson J, Picard JK, Edwards A, Kioussis D, Cooke A: Prevention of insulin- dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature 345:727-729, 1990
35. sup to the development of insulitis in non-obese diabetic mice. Nature 345:722-724, 1990
36. Bohme J, Schuhbaur B, Kanagawa O, Benoist C, Mathis D: MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science 249:293-295, 1990
37. d transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc Natl Acad Sci U S A 90:9566-9570, 1993
38. g7 β-chain diminshes the spontaneous incidence of insulin-dependent diabetes mellitus. J Immunol 154:5567-5575, 1995
39. Slattery RM, Miller JFAP, Heath WR, Charlton B: Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes. Proc Natl Acad Sci U S A 90:10808-10810, 1993
40. Parish NM, Chandler P, Quartey-Papafio R, Simpson E, Cooke A: The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes. Eur J Immunol 23:2667-2675, 1993
41. Serreze D, Leiter E: Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium. J Immunol 147:1222-1229, 1991
42. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd ed. Plainview, NY, Cold Spring Harbor Laboratory Press, 1989
43. Kunkel TA, Roberts JD, Zakour RA: Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 154:367-382, 1987
44. Hogan B, Constantini F, Lacy E: Manipulating the Mouse Embryo: A Laboratory Manual. Plainview, NY, Cold Spring Harbor Laboratory Press, 1986
45. Kappler JW, Marrack P: The role of H-2 linked genes in helper T-cell function. IV. Importance of T-cell genotype and host environment in I-region and Ir gene expression. J Erp Med 148:1510-1522, 1978
46. Oi VT, Jones PP, Goding JW, Herzenberg LA, Herzenberg LA: Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr Top Microbiol Immunol 81:115-120, 1978
47. Swain SL, Weinberg AD, English M, Huston G: IL-4 directs the development of Th2-like helper effectors. J Immunol 145:3796-3806, 1990
48. Abrams JS, Roncarolo MG, Yssel H, Anderson U, Gleich GJ, Silver JE: Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL- 10 and IL-5 in clinical samples. Immunol Rev 127:5-24,1992
49. Harlow E, Lane D: Antibodies: A Laboratory Manual. Plainview, NY, Cold Spring Harbor Laboratory Press, 1988
50. Gilfillan S, Aiso S, Michie SA, McDevitt HO: Immune deficiency due to high copy numbers of an Aßktransgene. Proc Natl Acad Sci U S A 87:7319-7323, 1990
51. Singer SM, Umetsu DT, McDevitt HO: High copy number I-Ab transgenes induce production of IgE through an interleukin 4-dependent mechanism. Proc Natl Acad Sci USA 93:2947-2952, 1996
52. g7 transgenic nonobese diabetic mouse line. Diabetes 46:1970-1974, 1997
53. Burstein HJ, Abbas AK: In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med 177:457-463, 1993
54. Adelstein S, Pritchard-Briscoe H, Anderson TA, Crosbie J, Gammon G, Loblay RH, Basten A, Goodnow CC: Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little serf antigen. Science 251:1223-1225, 1991
55. Lo D, Freedman J, Hesse S, Palmiter RD, Brinster RL, Sherman LA: Peripheral tolerance to an islet cell specific hemagglutinin transgene affects both CD4+ and CD8+ T Cells. Eur J Immunol 22:1013-1022, 1992
56. Peterson JD, Karpus WJ, Clatch RJ, Miller SD: Split tolerance of Th1 and Th2 cells in tolerance to Theiler's muirine encephalomyelitis virus. Eur J Immunol 23:46-55, 1993
57. Khoury SJ, Hancock WW, Weiner HL: Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176:1355-1364, 1992
58. + T cells and their roles in the induction and prevention of autoimmunity. Immunol Rev 123:37-64, 1991
59. Thai A-C, Eisenbarth GS: Natural history of IDDM. Diabetes Rev 1:1-14, 1993